Mudit K. Jain - Net Worth and Insider Trading

Mudit K. Jain Net Worth

The estimated net worth of Mudit K. Jain is at least $8 Million dollars as of 2024-05-22. Mudit K. Jain is the Director of CVRx Inc and owns about 936,783 shares of CVRx Inc (CVRX) stock worth over $8 Million. Mudit K. Jain is also the Director of Inspire Medical Systems Inc and owns about 820 shares of Inspire Medical Systems Inc (INSP) stock worth over $130,483. Details can be seen in Mudit K. Jain's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mudit K. Jain has not made any transactions after 2022-02-28 and currently still holds the listed stock(s).

Transaction Summary of Mudit K. Jain

To

Mudit K. Jain Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mudit K. Jain owns 4 companies in total, including Inspire Medical Systems Inc (INSP) , iRhythm Technologies Inc (IRTC) , and Asensus Surgical Inc (ASXC) among others .

Click here to see the complete history of Mudit K. Jain’s form 4 insider trades.

Insider Ownership Summary of Mudit K. Jain

Ticker Comapny Transaction Date Type of Owner
INSP Inspire Medical Systems Inc 2020-01-08 director & 10 percent owner
IRTC iRhythm Technologies Inc 2016-10-19 10 percent owner
ASXC Asensus Surgical Inc 2013-09-03 10 percent owner
2022-02-28 director

Mudit K. Jain Latest Holdings Summary

Mudit K. Jain currently owns a total of 2 stocks. Among these stocks, Mudit K. Jain owns 936,783 shares of CVRx Inc (CVRX) as of February 28, 2022, with a value of $8 Million and a weighting of 98.43%. Mudit K. Jain also owns 820 shares of Inspire Medical Systems Inc (INSP) as of January 8, 2020, with a value of $130,483 and a weighting of 1.57%.

Latest Holdings of Mudit K. Jain

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CVRX CVRx Inc 2022-02-28 936,783 8.75 8,192,167
INSP Inspire Medical Systems Inc 2020-01-08 820 159.13 130,483

Holding Weightings of Mudit K. Jain


Mudit K. Jain Form 4 Trading Tracker

According to the SEC Form 4 filings, Mudit K. Jain has made a total of 3 transactions in CVRx Inc (CVRX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in CVRx Inc is the acquisition of 600 shares on February 28, 2022, which cost Mudit K. Jain around $5,418.

According to the SEC Form 4 filings, Mudit K. Jain has made a total of 8 transactions in Inspire Medical Systems Inc (INSP) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Inspire Medical Systems Inc is the sale of 1,000 shares on January 8, 2020, which brought Mudit K. Jain around $76,470.

Insider Trading History of Mudit K. Jain

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mudit K. Jain Trading Performance

GuruFocus tracks the stock performance after each of Mudit K. Jain's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mudit K. Jain is -26.29%. GuruFocus also compares Mudit K. Jain's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mudit K. Jain within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mudit K. Jain's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mudit K. Jain

Average Return

Average return per transaction

Outperforming Transactions

1 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -19.9
Relative Return to S&P 500(%) -20.87

Mudit K. Jain Ownership Network

Ownership Network List of Mudit K. Jain

No Data

Ownership Network Relation of Mudit K. Jain


Mudit K. Jain Owned Company Details

What does Inspire Medical Systems Inc do?

Who are the key executives at Inspire Medical Systems Inc?

Mudit K. Jain is the director & 10 percent owner of Inspire Medical Systems Inc. Other key executives at Inspire Medical Systems Inc include Chief Financial Officer Richard Buchholz , director & 10 percent owner & CEO and President Timothy P. Herbert , and Chief Technology Officer John Rondoni .

Inspire Medical Systems Inc (INSP) Insider Trades Summary

Over the past 18 months, Mudit K. Jain made no insider transaction in Inspire Medical Systems Inc (INSP). Other recent insider transactions involving Inspire Medical Systems Inc (INSP) include a net sale of 8,571 shares made by Jerry C Griffin , a net sale of 172,992 shares made by Timothy P. Herbert , and a net sale of 20,840 shares made by John Rondoni .

In summary, during the past 3 months, insiders sold 124,976 shares of Inspire Medical Systems Inc (INSP) in total and bought 0 shares, with a net sale of 124,976 shares. During the past 18 months, 311,989 shares of Inspire Medical Systems Inc (INSP) were sold and 100 shares were bought by its insiders, resulting in a net sale of 311,889 shares.

Inspire Medical Systems Inc (INSP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Inspire Medical Systems Inc Insider Transactions

No Available Data

Mudit K. Jain Mailing Address

Above is the net worth, insider trading, and ownership report for Mudit K. Jain. You might contact Mudit K. Jain via mailing address: C/o Treo Ventures, 140 Washington Street, Suite 200, Reno Nv 89503.

Discussions on Mudit K. Jain

No discussions yet.